Drug intelligence / Profile preview

simvastatin combination

Development stage
Unknown
Lead developer
Merck
Modality
Small Molecules
Administration
Oral
01

Overview

Simvastatin combinations are pharmaceutical products that contain simvastatin together with one or more other active ingredients—most commonly ezetimibe or nicotinic acid. These combinations are used to treat high cholesterol and triglyceride levels in the blood and may help prevent certain types of heart problems in patients at high risk. Simvastatin is an HMG-CoA reductase inhibitor (statin) that works by blocking an enzyme needed for cholesterol synthesis in the liver. Ezetimibe is a cholesterol absorption inhibitor that reduces intestinal absorption of dietary and biliary cholesterol. Nicotinic acid (niacin) lowers LDL cholesterol and triglycerides while raising HDL cholesterol through multiple mechanisms. These fixed-dose combinations are indicated for primary hypercholesterolemia (including heterozygous familial hypercholesterolemia), homozygous familial hypercholesterolemia, mixed dyslipidemia, and prevention of cardiovascular events in appropriate populations[1][6].

Brand names
VytorinSimvotin TabSimcard -EZSimstat NSimlo -EZStarstat -EZ (20)Starstat -EZSimvas -EZLipicon -SSimvastol -N
Other names
simvastatin combination
02

Targets

NPC1L1 (Niemann-pick C1-Like 1 transporter)

Beyond the preview

Go deeper on simvastatin combination.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on simvastatin combination.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call